An electrochemical self-monitoring device for rapid nucleic acid based testing of HIV-1
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00042
- Awardee
-
Vitruvian Bio, LLC UEI JHJJANE1ALC6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,968
Award facts
- Opportunity
-
- SBIRPHS20241 Solicitation number
- Contract value 100% obligated
- $299,968.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21202, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,968 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology contract is set aside for small businesses and is a firm fixed-price definitive contract with an ultimate completion date of April 14, 2025. Vitruvian Bio, LLC is a Maryland-based limited liability company that focuses on innovative biomedical solutions, particularly in the realm of infectious disease diagnostics and point-of-care testing technologies.
Quick answers
Who was awarded contract 75N93024C00042?
75N93024C00042 was awarded to Vitruvian Bio, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.
How much is contract 75N93024C00042 worth?
The government has obligated $299,968 on 75N93024C00042.
Was contract 75N93024C00042 competed?
The extent of competition for 75N93024C00042 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award